In our recent publication on bioactive guided isolation of compounds from
Physalis longifolia (Solanaceae) novel anti-proliferative agents withalongolides A (
4) and B (
5), and their highly cytotoxic analogues, withalongolide A 4,19,27-triacetate (
4a) and withalongolide B 4,19-diacetate (
5a) were elucidated. In this study, the two lead compounds (
4,
5) were re-isolated in gram quantities for the purpose of further analogue preparation and
in vivo testing that would continue to probe structure–activity relationships. During this process, two additional withanolides, named withalongolides O (
1) and P (
2), were elucidated. Their structures were determined by spectroscopic techniques with
1 being subsequently confirmed by X-ray crystallographic analysis. Utilizing a MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2
H-tetrazolium] viability assay, withalongolide O (
1) and its 4,7-diaceatate (
1a), both containing the functionalities of Δ
2-1-oxo- in A ring, a 5β,6β-epoxy in B ring, and a lactone ring in the nine-carbon side chain, exhibited potent cytotoxicity against human head and neck squamous cell carcinoma (JMAR and MDA-1986), melanoma (B16F10 and SKMEL-28), and normal fetal lung fibroblast (MRC-5) cells with IC
50 values in the range between 0.15 and 2.95 µ
M. In addition, the previously reported α orientation of 7-acetate group in acnistins C and D should be revised to the β orientation on the basis of NMR data comparison.
View full abstract